We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.15 | 0.42% | 35.65 | 35.40 | 35.90 | 36.50 | 34.05 | 36.50 | 425,707 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.25 | 106.45M |
TIDMFUM
RNS Number : 4913X
Futura Medical PLC
24 November 2017
24 November 2017
Futura Medical plc
("Futura" or "the Company")
Block Listing Update
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology makes the following update on its block listing, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies. All figures relate to options over ordinary shares of 0.2 pence each.
The table below provides further detail.
Name of company: Futura Medical plc Name of scheme: Unapproved Share Option Scheme ("USOS") EMI Share Option Scheme ("EMI") Period of return: From: 25 May 2017 To: 24 November 2017 Number and class of securities not issued under the scheme(s) at start of period USOS: 2,446,110 EMI: 3,021,390 Total: 5,467,500 Number of securities issued under the scheme(s) USOS: - during the period Number of securities lapsed under the scheme(s) during the period EMI: - USOS: 50,000 EMI: 350,000 Balance under the scheme(s) of securities not yet issued at the end of the period USOS: 2,396,110 EMI: 2,671,390 Total: 5,067,500 Number and class of securities originally USOS: 814,424 on 25 May 2011, 1,202,280 on 8 October admitted and the date of admission 2013, 1,466,208 on 25 May 2017 USOS Total: 3,482,912 EMI: 1,520,576 on 25 May 2011, 1,467,720 on 8 October 2013 1,893,792 on 25 May 2017 EMI Total: 4,882,088 Total: 8,365,000 Name of contact: Derek Martin, Chief Financial Officer Telephone number of contact: +44 (0) 1483 685 670
For further information please contact:
Futura Medical plc James Barder, Chief Executive Tel: +44 (0) 1483 685 670 Email to: james.barder@futuramedical.com www.futuramedical.com N+1 Singer (Nominated Adviser and Broker) Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496 Corporate Finance 3000 For media enquiries please contact: Buchanan Mark Court / Sophie Cowles Tel: +44 (0) 20 7466 / Stephanie Watson 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPGGWUGUPMGWC
(END) Dow Jones Newswires
November 24, 2017 08:08 ET (13:08 GMT)
1 Year Futura Medical Chart |
1 Month Futura Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions